Humacyte, Inc. (HUMA)
0.4627
+0.06
(+15.50%)
USD |
NASDAQ |
Oct 27, 12:31
Humacyte Price : 0.4627 for Oct. 27, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 26, 2026 | 0.46 | 0.4617 | 0.391 | 0.4006 | 3.976M |
| Oct 23, 2026 | 0.42 | 0.4398 | 0.3989 | 0.4354 | 2.608M |
| Oct 22, 2026 | 0.41 | 0.4199 | 0.40 | 0.4131 | 2.259M |
| Oct 21, 2026 | 0.41 | 0.42 | 0.3924 | 0.4112 | 4.176M |
| Oct 20, 2026 | 0.3921 | 0.4155 | 0.39 | 0.406 | 4.893M |
| Oct 19, 2026 | 0.4284 | 0.4394 | 0.3913 | 0.4011 | 4.691M |
| Oct 16, 2026 | 0.45 | 0.4597 | 0.4201 | 0.429 | 5.971M |
| Oct 15, 2026 | 0.3656 | 0.4456 | 0.3512 | 0.4395 | 20.79M |
| Oct 14, 2026 | 0.3634 | 0.3791 | 0.337 | 0.3541 | 5.431M |
| Oct 13, 2026 | 0.3896 | 0.3908 | 0.3555 | 0.3589 | 12.35M |
| Oct 12, 2026 | 0.40 | 0.4130 | 0.3868 | 0.3896 | 16.35M |
| Oct 09, 2026 | 0.44 | 0.449 | 0.391 | 0.4053 | 8.598M |
| Oct 08, 2026 | 0.4748 | 0.4799 | 0.4367 | 0.4471 | 5.485M |
| Oct 07, 2026 | 0.4792 | 0.4799 | 0.46 | 0.4723 | 3.913M |
| Oct 06, 2026 | 0.501 | 0.5095 | 0.4724 | 0.478 | 4.281M |
| Oct 05, 2026 | 0.52 | 0.5223 | 0.4848 | 0.50 | 6.449M |
| Oct 02, 2026 | 0.5061 | 0.5343 | 0.5032 | 0.5215 | 5.395M |
| Oct 01, 2026 | 0.52 | 0.5283 | 0.5007 | 0.5029 | 2.995M |
| Sep 30, 2026 | 0.54 | 0.548 | 0.5104 | 0.5177 | 5.749M |
| Sep 29, 2026 | 0.5494 | 0.55 | 0.5312 | 0.5327 | 3.612M |
| Sep 28, 2026 | 0.55 | 0.5689 | 0.5316 | 0.5472 | 4.959M |
| Sep 25, 2026 | 0.56 | 0.5713 | 0.55 | 0.5573 | 2.620M |
| Sep 24, 2026 | 0.5599 | 0.5731 | 0.543 | 0.5687 | 2.835M |
| Sep 23, 2026 | 0.588 | 0.588 | 0.5556 | 0.5657 | 3.432M |
| Sep 22, 2026 | 0.5876 | 0.6079 | 0.5811 | 0.5828 | 3.470M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amgen, Inc. | 446.97 |
| Altimmune, Inc. | 2.08 |
| Protalix Biotherapeutics, Inc. | 2.52 |
| Taysha Gene Therapies, Inc. | 4.16 |
| Agenus, Inc. | 6.29 |
Price Related Metrics
| PS Ratio | 42.38 |
| PEG Ratio | -0.1303 |
| Price to Book Value | 4.112 |
| Earnings Yield | -105.8% |
| Market Cap | 128.54M |
| PEGY Ratio | -0.1303 |